These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29615471)

  • 1. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT
    Xu X; Wei Y; Guo Q; Zhao S; Liu Z; Xiao T; Liu Y; Qiu Y; Hou Y; Zhang G; Wang K
    J Pharmacol Exp Ther; 2018 Jun; 365(3):624-635. PubMed ID: 29615471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological and antidepressant-like effects of ZY-1408: A novel serotonin/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist.
    Gao N; Tiliwaerde M; Zheng W; Xiong J; Li X; Jin Z
    Neuropharmacology; 2021 Jan; 182():108376. PubMed ID: 33122031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors.
    Xue R; Li Y; He XH; Jin ZL; Fan SY; Zhang TT; Li NM; Yuan L; Zheng AP; Zhong BH; Li YF; Zhang YZ
    J Psychopharmacol; 2017 Mar; 31(3):377-386. PubMed ID: 28245750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
    Auclair AL; Martel JC; Assié MB; Bardin L; Heusler P; Cussac D; Marien M; Newman-Tancredi A; O'Connor JA; Depoortère R
    Neuropharmacology; 2013 Jul; 70():338-47. PubMed ID: 23499664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
    J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
    Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.
    Fan QY; Xue R; Li Y; Zhang TT; He XH; Fan SY; Li YF; Zhong BH; Zhang YZ; Li J
    CNS Neurosci Ther; 2016 Aug; 22(8):700-6. PubMed ID: 27207183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
    Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
    Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
    Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
    Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Li XR; Tang Y; Xiong J; Chen HX; Xue R; Li YF
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):544-56. PubMed ID: 25638027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
    Singh P; Singh TG
    Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
    Kawai H; Machida M; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
    Biol Pharm Bull; 2018; 41(2):213-219. PubMed ID: 29386481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.
    Yamada K; Kobayashi M; Mori A; Jenner P; Kanda T
    Pharmacol Biochem Behav; 2013 Dec; 114-115():23-30. PubMed ID: 24201052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence.
    Mizutani H; Sakakibara F; Komuro M; Sasaki E
    J Pharmacol Exp Ther; 2018 Aug; 366(2):322-331. PubMed ID: 29875227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor.
    Zhang TT; Xue R; Zhu L; Li J; Fan QY; Zhong BH; Li YF; Ye CY; Zhang YZ
    Acta Pharmacol Sin; 2016 Sep; 37(9):1154-65. PubMed ID: 27424654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-depressant effects of phthalazinone-based triple-acting small molecules against 5-HT
    Kim J; Cha E; Park WK; Lee HY; Lim SM; Kim HJ; Pae AN
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126882. PubMed ID: 31889666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.